STAT

MARCH 6, 2024

WASHINGTON — President Biden wants to more than double the size of Medicare’s new drug price negotiation program and will preview the plan in his State of the Union address, the White House announced Wednesday.

Drug Pricing 348

Drug Pricing 348

STAT

JANUARY 25, 2024

Bernie Sanders on Thursday jabbed the CEO of Merck for telling congressional staff that he didn’t have the expertise to testify at a Senate hearing on prescription drug prices because he’s a tax attorney.

Drug Pricing 358

Drug Pricing 358

STAT

JANUARY 18, 2024

WASHINGTON — Senate health committee chair Bernie Sanders has taken a step toward subpoenaing the CEOs of Johnson & Johnson and Merck related to an investigation into high drug prices in the United States, he announced Thursday. Read the rest…

Drug Pricing 351

Drug Pricing 351

STAT

JANUARY 31, 2024

— Wednesday was the first time that a federal judge asked questions in-person of drug industry lawyers who are trying to stop Medicare from negotiating drug prices. WILMINGTON, Del. It didn’t go well for them.

Drug Pricing 354

Drug Pricing 354

STAT

JUNE 12, 2024

This is Part 1 of “Behind the Counter,” an in-depth video series demystifying the complex world of patents and drug pricing. Prescription drug costs are remarkably higher in the United States than in other countries, so it’s no surprise that more than half of U.S.

Drug Pricing 282

Drug Pricing 282

STAT

JULY 15, 2024

Medicare’s new guidelines cover how it will conduct the drug price negotiations authorized by the Inflation Reduction Act. It will also deter companies from doing research on existing medicines to create improved versions that are more effective and have fewer side effects.

Drug Pricing 236

Drug Pricing Hospitals 236

STAT

MARCH 1, 2024

WASHINGTON — A federal judge in Delaware on Friday ruled against AstraZeneca in a case challenging the constitutionality of Medicare’s new drug price negotiation program. Colm Connolly, chief judge of the U.S. District Court of Delaware, ruled against the company on all its major arguments.

Drug Pricing 267

Drug Pricing 267

STAT

FEBRUARY 1, 2024

WASHINGTON  — The Biden administration is making its opening offers to pharmaceutical companies in its brand-new Medicare drug price negotiation program on Thursday, administration officials said. And that’s about all they said.

Drug Pricing 295

Drug Pricing Pharmaceutical Companies Pharmaceutical Companies 295

STAT

MAY 6, 2024

The changing landscape of drug pricing policy in the U.S. Drug policy changes are being influenced by perceptions of the value of novel medicines relative to their budgetary impacts, with some believing that many medicines may not be worth their cost, creating an important role for health technology assessments (HTA).

Drug Pricing 330

Drug Pricing 330

pharmaphorum

SEPTEMBER 18, 2024

PBM Express Scripts has sued the FTC, claiming its recent report on the sector's role in drug pricing is defamatory and should be retracted

Drug Pricing 120

Drug Pricing 120

STAT

FEBRUARY 1, 2024

So my enterprising colleague John Wilkerson trekked up to Wilmington to give you an inside view on how a key judge viewed arguments in the first court test of the new Medicare drug price negotiation program. Read the rest…

Drug Pricing 180

Drug Pricing 180

STAT

MAY 8, 2023

EQRx, a company that aimed to lower drug prices by introducing inexpensive me-too medicines, said Tuesday that it has abandoned that plan and is laying off nearly 60% of its workforce. Continue to STAT+ to read the full story…

Drug Pricing 290

Drug Pricing Hospitals 290

STAT

AUGUST 24, 2023

At the start and halfway points of each year, many pharmaceutical companies raise drug prices to bolster revenue and reportedly fund new research. “It’s not just all selling new drugs,” said Juliette Cubanski, deputy director of the Program on Medicare Policy at Kaiser Family Foundation.

Drug Pricing 207

Drug Pricing Pharmaceutical Companies Pharmaceutical Companies 207

STAT

FEBRUARY 8, 2024

Bernie Sanders’ prescription drug pricing theater. WASHINGTON — Call it Sen. The hearing, featuring Merck CEO Robert Davis, Johnson and Johnson CEO Joaquin Duato, and Bristol Myers Squibb CEO Chris Boerner, was designed to draw public interest, and in that respect, it worked.

Drug Pricing 237

Drug Pricing 237

pharmaphorum

SEPTEMBER 12, 2024

Explore the ins and outs of Medicare drug pricing negotiations with Alice Valder Curran on this insightful podcast. Learn more about what comes next in this crucial healthcare sector.

Drug Pricing 95

Drug Pricing 95

STAT

MARCH 9, 2023

WASHINGTON — President Biden made lowering drug prices a key part of his budget with proposals to expand Medicare drug price negotiation, squeeze more rebates out of drug companies, and lower the cost of insulin for everyone with insurance. The request made Thursday also details a $7.2

Drug Pricing 232

Drug Pricing 232

STAT

SEPTEMBER 8, 2022

The passage of the Inflation Reduction Act brings a new era to drug pricing in the United States. After decades of being an outlier, it now joins every other developed nation in having the federal government engaged in negotiating drug pricing.

Drug Pricing 226

Drug Pricing 226

STAT

FEBRUARY 8, 2024

LONDON — Medicare’s first-ever drug pricing negotiations are officially underway. But neither government officials nor drugmakers are wanting to show their cards, at least publicly.

Drug Pricing 253

Drug Pricing Diabetes 253

STAT

AUGUST 15, 2024

Are pharma companies still fearful of the Inflation Reduction Act? Will Lykos’ FDA rejection and recent publication retractions pull down the entire psychedelics industry? And what would you name a commercial psychotherapy treatment? We discuss all that and more on this week’s episode of “The Readout LOUD.”

Drug Pricing 226

Drug Pricing 226

PharmaVoice

AUGUST 18, 2022

Now that Medicare will be able to negotiate drug prices under the Inflation Reduction Act, the industry can expect to see some changes. Here are some tips on how to navigate the changing tide.

Drug Pricing 262

Drug Pricing 262

STAT

DECEMBER 6, 2023

judge ruled that Minnesota must temporarily halt a controversial law that is designed to provide transparency into prescription drug pricing over concerns that it is unconstitutional. In a victory for the pharmaceutical industry, a U.S.

Drug Pricing 261

Drug Pricing Pharmaceutical Manufacturing 261

pharmaphorum

AUGUST 16, 2024

Joe Biden and Kamala Harris reaffirm commitment to Medicare drug pricing negotiations in first joint rally since ticket swap.

Drug Pricing 108

Drug Pricing 108

PharmaVoice

AUGUST 31, 2023

Medicare just announced its first-ever drug price negotiations and legislators are quickly pushing to broaden the program.

Drug Pricing 147

Drug Pricing 147

STAT

AUGUST 15, 2023

As STAT reported recently, the Senate Committee on Health, Education, Labor, and Pensions (HELP) has indicated that it will not consider the nomination of Monica Bertagnolli as director of the National Institutes of Health unless she pledges to take specific steps to reduce drug prices. Read the rest…

Drug Pricing 222

Drug Pricing 222

STAT

MAY 24, 2023

The goal is to give states more leverage in price negotiations by forcing drugmakers to share and publish details about their pricing data. The government would collect specific drug pricing information from makers of up to 10 particularly high-cost drugs.

Drug Pricing 222

Drug Pricing 222

STAT

MAY 11, 2023

is pursuing the drug pricing reforms at the behest of Senate Majority Leader Chuck Schumer (D-N.Y.), The markup came just a day after the same panel held a major hearing on PBM and drugmakers’ role in high insulin prices. Chairman Bernie Sanders (I-Vt.)

Drug Pricing 247

Drug Pricing Packaging 247

STAT

OCTOBER 2, 2023

… A federal court judge allowed the new Medicare drug price negotiation program to proceed while the court deliberates whether it is constitutional , STAT reports. Meanwhile, Novo Nordisk became the latest pharmaceutical company to file a lawsuit against the Medicare drug price negotiation program , Bloomberg Law tells us. The

Drug Pricing 234

Drug Pricing Pharmaceutical Companies Pharmaceutical Companies 234

STAT

AUGUST 20, 2024

You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine.    Sign up here  to receive it in your inbox on Tuesdays and Thursdays. Hello and happy Tuesday!

Drug Pricing 254

Drug Pricing Hospitals 254

STAT

JULY 26, 2023

They’re focused this summer on reining in pharmacy middlemen to make the system fairer — but none of their many proposals will actually tackle the core dynamic that has incentivized higher drug prices. There are major packages on so-called PBM reform percolating in at least six different congressional committees.

Drug Pricing 208

Drug Pricing Packaging Pharmaceutical Companies Pharmaceutical Companies 208

STAT

MARCH 8, 2023

WASHINGTON — Medicare officials are still hammering out the technical specifics of how the massive program will start to negotiate drug prices — let alone the substantive ones, Medicare chief Meena Seshamani said at a STAT event Tuesday.

Drug Pricing 186

Drug Pricing 186

Drug Patent Watch

SEPTEMBER 12, 2024

This strategy, known as the ‘Rule of Three,’ is a game-changer in the battle against soaring drug prices. The ‘Rule of Three’ is a relatively… Source

Drug Pricing 78

Drug Pricing 78

STAT

DECEMBER 1, 2022

At a time when many Americans are clamoring for more transparency into prescription drug pricing, one key provider of that data is making it harder to access the information.

Drug Pricing 223

Drug Pricing Packaging 223

STAT

JANUARY 23, 2024

Want to stay on top of the science and politics driving biotech today?    Sign up  to get our biotech newsletter in your inbox. Hello, everyone. Damian here with a look at some polarizing cancer data, a strange CEO transition, and the importance of New Year cheer. Read the rest…

Drug Pricing 163

Drug Pricing Drug Development 163

PharmaVoice

AUGUST 9, 2024

Here’s what the leaders of the companies with the 10 drugs in the first wave of price negotiations with Medicare said about how the new prices will impact their portfolio.

Drug Pricing 223

Drug Pricing 223

Pharmaceutical Commerce

APRIL 8, 2024

In an interview with Pharma Commerce Editor Nicholas Saraceno, Ed Schoonveld, Value & Access Advisor, Schoonveld Advisory, offers his thoughts on lower drug prices in the US and provides a sneak peak into future PC features.

Drug Pricing 105

Drug Pricing 105

Drug Channels

MARCH 6, 2023

Experts from across the industry will discuss how current and future drug pricing transparency regulations will impact commercialization, reimbursement, pricing and compliance practices. Drug Channels readers will save 10% off when they use code 23DRCH10 and register prior to March 31, 2023.*

Drug Pricing 98

Drug Pricing 98

STAT

NOVEMBER 2, 2023

WASHINGTON — A key Senate panel announced it will consider more policies to regulate pharmacy middlemen and ensure patients aren’t paying more than insurers do for medications. The package crafted by Senate Finance Chair Ron Wyden (D-Ore.) and Mike Crapo (R-Idaho) is slated to be marked up on Nov.

Packaging 328

Packaging Drug Pricing 328